Barclays analyst Terry Ma lowered the firm’s price target on First American (FAF) to $69 from $72 and keeps an Equal Weight rating on the shares. The key themes heading into 2025 for the ...

Wealth Enhancement Advisory Services LLC increased its holdings in shares of First American Financial Co. (NYSE:FAF – Free Report) by 16.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 17,

In a report released today, Terry Ma from Barclays maintained a Hold rating on American Express (AXP – Research Report), with a price target of

Barclays share price has moved sideways in the past few weeks. BARC peaked, formed a double-top pattern at 272.90 in December, and dropped to 263p today. It has rallied by over 315% from its lowest level in 2020,

Barclays analyst Terry Ma maintained a Hold rating on AGNC Investment (AGNC – Research Report) today and set a price target of $9.00. The

With Donald Trump promising new tariffs against China after he’s inaugurated Monday, Joe Tsai has concerns about US-China relations.

Shell got one. So did the pipeline company Enbridge. And last summer, energy giant Drax got its biggest one to date, worth more than half a billion dollars.

Vedanta Resources Secures USD 300 Million Loan for Debt Refinancing Vedanta Resources has secured USD 300 million in loans from Barclays, First Abu Dhabi Bank, and Mashreq to refinance its 2024 and 2026 bonds. The company is also looking to upsize the deal ...

Substitute Darwin Nunez’s stoppage-time double gave Liverpool a 2-0 win at Brentford on Saturday, as the Premier League leaders left it late to record their first league win of 2025.

Aston Villa striker Ollie Watkins proved a thorn in Arsenal’s side yet again as he completed his side’s comeback with the equaliser in a 2-2 draw that damaged the London club’s Premier League title hopes this morning.

2024 was a stellar year for banking giants in the United States. According to a report in the Financial Times, the seven largest banks in the country by deposits accounted for 56% of the industry’s profits during the first nine months of the year, up from 48% during the same period in 2023.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?